UFP Technologies (UFPT) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
7 Jun, 2026Opening remarks and agenda
Meeting called to order with introductions of board members and officers, outlining the agenda and voting procedures.
Shareholders were informed about how to vote and submit questions during the virtual meeting.
Board and executive committee updates
Directors and officers introduced, including committee chairs and executive leadership.
Shareholder proposals
Three proposals presented: election of seven directors, advisory vote on executive compensation, and ratification of the independent auditor.
Details of each proposal and voting requirements were explained.
Partial view of Summaries dataset, powered by Quartr API
Latest events from UFP Technologies
- Record Q2 sales and net income, strong MedTech growth, and ongoing investments in capacity.UFPT
Q2 2026 - Exclusive materials, strategic acquisitions, and global expansion drive robust medtech growth.UFPT
15th Annual Midwest IDEAS Investor Conference - Targeting 12–18% growth, the company invests in medtech innovation and global expansion.UFPT
16th Annual East Coast IDEAS Conference - Global MedTech manufacturer targets 12-18% annual growth with proven scale and innovation.UFPT
Investor presentation - Q1 2026 revenue up 4.1% to $154.2M, with MedTech growth and margin gains amid ongoing risks.UFPT
Q1 2026 - Virtual annual meeting to vote on directors, executive pay, auditor, and highlight governance best practices.UFPT
Proxy filing - Exclusive materials, strategic acquisitions, and strong contracts fuel high-margin growth.UFPT
47th Annual Raymond James Institutional Investor Conference - MedTech-focused manufacturer targets 12–18% revenue growth and 17–20% margins via innovation and acquisitions.UFPT
Investor presentation - Net income up 15.8% and sales up 19.5% to $602.8M, driven by medical market growth.UFPT
Q4 2025